Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
Public ClinicalTrials.gov record NCT02859766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Safety and Systemic Pharmacokinetics After Single and Repeat Doses of Abicipar Pegol (AGN-150998) Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and characterize the systemic pharmacokinetics (PK) of free and vascular endothelial growth factor (VEGF)-bound abicipar following single and multiple intravitreal injections of abicipar pegol in treatment-naïve patients with neovascular age-related macular degeneration (AMD).
Study identification
- NCT ID
- NCT02859766
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 6, 2016
- Primary completion
- Oct 19, 2017
- Completion
- Oct 19, 2017
- Last update posted
- Feb 7, 2018
2016 – 2017
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Consultants of Arizona | Gilbert | Arizona | 85296 | — |
| Win Retina | Arcadia | California | 91006 | — |
| Retina Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Atlantis Retina Institute (Atlantis Eyecare) | Huntington Beach | California | 92647 | — |
| Jacobs Retina Center, Shiley Eye Institute, UCSD | La Jolla | California | 92093 | — |
| California Eye Specialists Medical Group, Inc-Private Clinic | Pasadena | California | 91107 | — |
| University of Miami | Coral Gables | Florida | 33146 | — |
| The Eye Institute of West Florida | Largo | Florida | 33770 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| East Florida Eye Insititute | Stuart | Florida | 34994 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Raj K. Maturi, MD | Indianapolis | Indiana | 46290 | — |
| Massachusetts Eye & Ear | Boston | Massachusetts | 02114 | — |
| Eyesight Ophthalmic Services, PA | Portsmouth | New Hampshire | 03801 | — |
| Caroline Eye Associates | Southern Pines | North Carolina | 28387 | — |
| Cole Eye Institute, Cleveland Clinic | Cleveland | Ohio | 44122 | — |
| Rocky Mountain Retina Consultants | Salt Lake City | Utah | 84107 | — |
| Davis Duehr Dean | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02859766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02859766 live on ClinicalTrials.gov.